Skip to content

G&A at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$6.85M+23.6%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$11.57M-14.5%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$11.45M+5.8%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$13.44M-44.8%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$20.36M+25.1%
Alumis Inc. logo
Alumis Inc.ALMS
$18.61M-16.5%

Segments

By segment

See full
Viaskin Peanut Segment$10.5M+87.5%

By product

See full
Expenses by function$4.6M+53.3%

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$923.31M+269%
Enterprise value$700.21M+188%
P/S159.6×+89.0×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's G&A?
DBV Technologies (DBVT) reported G&A of $10.5M in Q1 2026.
How has DBV Technologies's G&A changed year-over-year?
DBV Technologies's G&A increased by 87.5% year-over-year, from $5.6M to $10.5M.
What is the long-term trend for DBV Technologies's G&A?
Over 4 years (2021 to 2025), DBV Technologies's G&A has grown at a 1.8% compound annual growth rate (CAGR), from $30.52M to $32.76M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.